Justin Chu

Dr Justin Chu is currently the Asisstant Dean of Academic Affairs NUS Medicine and an Associate Professor in the Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore. He is holding a joint appointment Senior Principal Investigator in the Institute of Molecular and Cell Biology, A STAR. Dr Chu is also the director of the largest research based high containment Biosafety Level 3 Facility in Singapore which is located in the Yong Loo Lin School of Medicine, NUS. Dr. Chu is actively engaged in the study of the molecular biology of human enteroviruses, Coronavirus SARS-CoV-2 as well as mosquito-borne viruses including Dengue, Zika, West Nile/Japanese Encephalitis and Chikungunya. The outcome of these studies have helped to pave the roadmap towards the development of a number of antiviral strategies (antivirals, vaccines, therapeutics antibodies, molecular inhibitors) that are now in the process of clinical translational evaluation for these medically important mosquito-borne viruses. Eight patents have also been generated from these current research.

Dr. Chu has published over 100 international peer-reviewed scientific publications, book chapters and over 160 conference papers. A number of these scientific papers are published in prestigious journals including Nature Communications, PNAS, PLoS Pathogens, Biomaterials, Journal of Biological Chemistry, Journal of Virology and Antiviral therapy. Dr Chu is currently serving as the associate editor and reviewer for a number of peer-reviewed journals in the areas of medical virology and anti-viral strategies.